These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 15560285

  • 1. [Sodium channels and multiple sclerosis].
    Colotto M, Danese C.
    Clin Ter; 2004 Jun; 155(6):245-8. PubMed ID: 15560285
    [Abstract] [Full Text] [Related]

  • 2. Axonal conduction and injury in multiple sclerosis: the role of sodium channels.
    Waxman SG.
    Nat Rev Neurosci; 2006 Dec; 7(12):932-41. PubMed ID: 17115075
    [Abstract] [Full Text] [Related]

  • 3. Sodium channels as molecular targets in multiple sclerosis.
    Waxman SG.
    J Rehabil Res Dev; 2002 Dec; 39(2):233-42. PubMed ID: 12051467
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increase of sodium channels in demyelinated lesions of multiple sclerosis.
    Moll C, Mourre C, Lazdunski M, Ulrich J.
    Brain Res; 1991 Aug 16; 556(2):311-6. PubMed ID: 1657307
    [Abstract] [Full Text] [Related]

  • 7. Astrocytes within multiple sclerosis lesions upregulate sodium channel Nav1.5.
    Black JA, Newcombe J, Waxman SG.
    Brain; 2010 Mar 16; 133(Pt 3):835-46. PubMed ID: 20147455
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Na+ channel expression along axons in multiple sclerosis and its models.
    Waxman SG, Craner MJ, Black JA.
    Trends Pharmacol Sci; 2004 Nov 16; 25(11):584-91. PubMed ID: 15491781
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Axonal dysfunction in chronic multiple sclerosis: meltdown in the membrane.
    Waxman SG.
    Ann Neurol; 2008 Apr 16; 63(4):411-3. PubMed ID: 18350590
    [No Abstract] [Full Text] [Related]

  • 12. Approaches to the development of pharmacological interventions in multiple sclerosis.
    Davis FA, Schauf CL.
    Adv Neurol; 1981 Apr 16; 31():505-10. PubMed ID: 6275674
    [No Abstract] [Full Text] [Related]

  • 13. [Physiopathology of the clinical manifestation of multiple sclerosis. Electrophysiological hypotheses].
    Cesaro P, Degos JD, Martin-Mondière C.
    Rev Neurol (Paris); 1984 Apr 16; 140(1):20-7. PubMed ID: 6364291
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
    Rovira A, León A.
    Eur J Radiol; 2008 Sep 16; 67(3):409-14. PubMed ID: 18434066
    [Abstract] [Full Text] [Related]

  • 16. [Pathophysiology of multiple sclerosis].
    Smith KJ.
    Rev Prat; 2006 Jun 30; 56(12):1299-303. PubMed ID: 16948217
    [Abstract] [Full Text] [Related]

  • 17. Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.
    Andrews HE, Nichols PP, Bates D, Turnbull DM.
    Med Hypotheses; 2005 Jun 30; 64(4):669-77. PubMed ID: 15694681
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC, Brink BP, Veerhuis R, van den Berg C, Vloet R, Yan R, Dijkstra CD, van der Valk P, Bö L.
    Ann Neurol; 2008 Jan 30; 63(1):16-25. PubMed ID: 18232012
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.